Flurbiprofen

A non-selective COX inhibitor inhibits human recombinant COX-1 and -2 with IC₅₀ values of 0.04 and 0.51 &microM, respectively.

A non-selective COX inhibitor inhibits human recombinant COX-1 and -2 with IC₅₀ values of 0.04 and 0.51 &microM, respectively.

A non-selective COX inhibitor inhibits human recombinant COX-1 and -2 with IC₅₀ values of 0.04 and 0.51 &microM, respectively.

A non-selective COX inhibitor inhibits human recombinant COX-1 and -2 with IC₅₀ values of 0.04 and 0.51 &microM, respectively.

A member of the 2-aryl propionic acid group of NSAIDs that reduces inflammation through inhibition of NF-&kappaB and AP-1 activation decreases survival of prostate tumor cells by inducing p75NTR protein expression inhibits the enzyme

An intermediate in the synthesis of Flurbiprofen.

An intermediate in the synthesis of Flurbiprofen.

An intermediate in the synthesis of Flurbiprofen.

4′-Hydroxy Flurbiprofen is a metabolite of Flurbiprofen, an anti-inflammatory used as an analgesic.

Underpad, 23 x 36 Fluff, Lt. Blue, 5/bg, 15 bg/cs (Continental US Only)""

Application Flurbiprofen is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic, analgesic, and antifungal activity. Oral formulations of flurbiprofen may be used to treat rheumatoid arthritis, osteoarthritis and anklylosing spondylitis.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the